A groundbreaking clinical trial has launched in Japan, offering a novel viral therapy that targets esophageal cancer cells. Early results suggest promising efficacy, marking the first such intervention worldwide.
Trending
- US Vice President JD Vance holds midterm election rally in Ohio hometown
- Ousting RFK Jr. Among the Priorities for This Doctor Running for Senate
- Crafting Tomorrow: How Streaming Flexibility Is Empowering Visionary Storytellers Like Vince Gilligan
- Pantera Capital Sees Institutional Inflows Driving Bitcoin Toward $80K Resistance
- Stabbing Incident at Edmonton Sikh Temple Leaves Two Injured, Suspect in Custody
- Soybean Futures Dip Despite Major Export Announcements
- Ed Martin Exits Justice Department Following Contentious Tenure
- Nigeria Investigates Fraudulent Government Agency Unveiled in Recent Probe
Keep Reading
